BioSpace News Archive

Business

Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers

Blueprint Medicines and Genentech, a member of the Roche Group, to co-commercialize pralsetinib and equally share profits in the U.S.

July 14, 2020
·
12 min read
Eurofins Publishes Robust Method to Analyse SARS-CoV-2 in Wastewater Samples, Providing Early Warning of Potential COVID-19 Outbreak at a Given Site

A study undertaken by Eurofins scientists has resulted in a robust method to analyse SARS-CoV-2 in wastewater samples, allowing for early detection of virus presence at a given site, before the virus spreads too broadly or as a way to monitor the effectiveness of containment measures put in place.

July 14, 2020
·
2 min read
Policy

FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)

Inzomelid is a potent, selective, orally-available, brain-penetrant NLRP3 inflammasome inhibitor intended for treatment of debilitating inflammatory diseases

July 14, 2020
·
3 min read
Munich and Boston-Based Viral Vector Pioneer Achieves 26% Growth for H1 2020 Despite COVID-19 Pandemic

SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene and cell therapy, announced financial results for the first half of 2020.

July 14, 2020
·
3 min read
Drug Development

New Global Phase 3 Program of BAN2401 Initiated in Preclinical (Asymptomatic) Alzheimer’s Disease

BioArctic AB announced that its business partner Eisai, in collaboration with Alzheimer’s Clinical Trials Consortium and Biogen, has initiated a new global Phase 3 clinical study with BAN2401, an anti-amyloid beta protofibril antibody.

July 14, 2020
·
2 min read
a-Si X-ray Flat Panel Detectors Market: Presence of Favorable Reimbursement Policies across the Globe to Shoot Up Demand

The global a-Si X-ray flat panel detectors market was valued at US$ 924.7 Mn in 2017 and is projected to expand at a cumulative annual growth rate of 5.2% from 2018 to 2026 according to a new report published by Transparency Market Research

July 14, 2020
·
5 min read
Polpharma Biologics Integrates Dutch Based Subsidiary, Bioceros, to Offer the Complete Spectrum of Services From Discovery to Commercial Supply.

In 2016, Polpharma Biologics acquired Dutch based Bioceros and their proprietary cell line development platform CHOBC®, as well as their comprehensive discovery, process development and analytical capabilities.

July 14, 2020
·
2 min read
Autologous Matrix-induced Chondrogenesis Market: Collagen to Lead the Pack as its Usage Gains Value in Tissue Engineering Sector

The global market for autologous matrix-induced chondrogenesis is expected to witness a high level of competition in the next few years, states a new market intelligence study by Transparency Market Research.

July 14, 2020
·
4 min read
Carglumic Acid Market: Carglumic Acid holds Potential in Accelerating Cancer Cell Suppression and Promoting Apoptosis

The demand within the global market for carglumic acid has been rising on account of advancements in the pharmaceutical industry, finds Transparency Market Research.

July 14, 2020
·
4 min read
Clinical Decision Support System Market: Cloud based clinical decision support system is estimated to grow at exponential growth rate

The demand in the global clinical decision support system market has been on the rise in recent years.

July 14, 2020
·
4 min read